about
Impact of the gut microbiota on the development of obesity and type 2 diabetes mellitusType 2 diabetes is associated with decreased PGC1α expression in epicardial adipose tissue of patients with coronary artery diseaseVEGF gene expression in adult human thymus fat: a correlative study with hypoxic induced factor and cyclooxygenase-2Adipose tissue gene expression of factors related to lipid processing in obesity.FABP4 dynamics in obesity: discrepancies in adipose tissue and liver expression regarding circulating plasma levels.Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control studyBenefits of polyphenols on gut microbiota and implications in human health.Intermittent hypoxia alters gut microbiota diversity in a mouse model of sleep apnoea.Gut microbiota composition in male rat models under different nutritional status and physical activity and its association with serum leptin and ghrelin levelsInsulin resistance is associated with specific gut microbiota in appendix samples from morbidly obese patientsContribution of polymorphisms in the apolipoprotein AI-CIII-AIV cluster to hyperlipidaemia in patients with gout.Endotoxin increase after fat overload is related to postprandial hypertriglyceridemia in morbidly obese patientsIncreased levels of anti-oxidized low-density lipoprotein antibodies are associated with reduced levels of cholesterol in the general population.Monounsaturated n-9 fatty acids and adipocyte lipolysis in rats.Effect of a specific supplement enriched with n-3 polyunsaturated fatty acids on markers of inflammation, oxidative stress and metabolic status of ear, nose and throat cancer patients.Patterns of insulin resistance in the general population of southeast Spain.Influence of age and sex on levels of anti-oxidized LDL antibodies and anti-LDL immune complexes in the general population.The -1131T>C SNP of the APOA5 gene modulates response to fenofibrate treatment in patients with the metabolic syndrome: a postprandial study.Association between MspI polymorphism of the APO AI gene and Type 2 diabetes mellitus.Fat overload aggravates oxidative stress in patients with the metabolic syndrome.Similar increase in oxidative stress after fat overload in persons with baseline hypertriglyceridemia with or without the metabolic syndrome.Inverse relation between levels of anti-oxidized-LDL antibodies and eicosapentanoic acid (EPA).Circulating antioxidant defences are decreased in healthy people after a high-fat meal.Molecular effect of fenofibrate on PBMC gene transcription related to lipid metabolism in patients with metabolic syndrome.Oxidative stress and metabolic changes after continuous positive airway pressure treatment according to previous metabolic disorders in sleep apnea-hypopnea syndrome patients.Serum 25-hydroxyvitamin D and adipose tissue vitamin D receptor gene expression: relationship with obesity and type 2 diabetes.Effect of the combination of the variants -75G/A APOA1 and Trp64Arg ADRB3 on the risk of type 2 diabetes (DM2).Inflammation, oxidative stress and metabolic syndrome: dietary modulation.Effect of apolipoprotein C3 and apolipoprotein A1 polymorphisms on postprandial response to a fat overload in metabolic syndrome patients.Altered Adipose Tissue DNA Methylation Status in Metabolic Syndrome: Relationships Between Global DNA Methylation and Specific Methylation at Adipogenic, Lipid Metabolism and Inflammatory Candidate Genes and Metabolic VariablesH. pylori Eradication Treatment Alters Gut Microbiota and GLP-1 Secretion in Humans.Redistribution of abdominal fat after a period of food restriction in rats is related to the type of dietary fatAutoantibodies to oxidized LDL and agePro12Ala sequence variant of the PPARG gene is associated with postprandial hypertriglyceridemia in non-E3/E3 patients with the metabolic syndromeInfluence of a fat overload on lipogenic regulators in metabolic syndrome patientsDietary fatty acids and insulin secretion: a population-based studyAnti-oxidized LDL antibody levels are reduced in women with hypertensionLong-term effects of varying consumption of ω3 fatty acids in ear, nose and throat cancer patients: assessment 1 year after radiotherapyTranscriptional Analysis of FOXO1, C/EBP-α and PPAR-γ2 Genes and Their Association with Obesity-Related Insulin ResistancePostprandial Circulating miRNAs in Response to a Dietary Fat Challenge
P50
Q27025506-71652AE9-5E89-41AC-8A6C-AF8DDC86C032Q28597641-050E6671-6E91-4EA3-9D9D-1D29B2E568DFQ33518570-B6A047E5-281E-422A-A0EF-0EE29C8CF0C8Q34037803-D8D846D7-AE06-4E22-BB78-DD2C6A147A94Q34472056-62E44AB8-02C9-411C-B4E5-40634AB645D8Q34596660-3D68C40F-8117-42DC-947C-4F68E323B18DQ34816017-8D4EB180-5620-4C68-A3D2-DE816DAF6BCCQ35533471-4AF851EB-8E3A-4469-A230-77A2AB2ADD00Q36881567-5B0571EF-7A5C-464F-A958-704ACCD85421Q37553868-A2459E84-2256-4836-9D3C-1373C75F17E4Q41875837-1C4FB936-D1BB-4149-84A7-CB98105CABE0Q42540372-C2F6C573-D0F6-4FFE-957C-6F18848BA080Q43931733-7C1A7304-756C-419B-AA24-999EFAF06916Q44671225-E0074A03-F2BF-450E-8C19-1EA57E5E8AF3Q44955771-2DC1C691-E4A4-4FFA-8CAC-EEF86C57C65AQ45032053-66129A2A-FDE5-4181-B990-706862E28CBCQ45190446-D0AD2C0D-F249-4334-8094-12FD0E90520CQ46062169-0B4AD55D-FC6E-45D5-A2FB-3ECBADB9A5A0Q46504558-9DF22127-3D10-4D76-BB24-7EBBA826F55BQ46588224-047E51C3-261F-48FA-BB55-7DA178751442Q46678724-D8E287D4-62AA-4426-8E8F-81EA9B1CBAD2Q46770544-5FC7EB7B-BCD0-43F7-831E-999F662F3D28Q46816011-D66173BA-2BAB-40B0-9EF9-A5F3A8859609Q48174139-CFFB3372-97A7-49F1-B782-FBD58876D6CCQ48392123-FE8A60B5-F95F-4964-9AA8-D54F0BB28788Q50451259-DE1B07BA-07BA-4210-A2E6-4AC112AA9B74Q50680507-2BC45F64-13F9-4811-8539-492D5537154AQ51332182-63DA3B23-E24E-46B1-87FA-1D214264E092Q51392730-D0214EB4-A344-4653-B85D-F77951A10BA0Q61818549-D5248C17-5F6F-44FB-AEE8-9C8A1977C3C8Q64935596-F51D6C4D-4EEF-428D-86FF-BE77AEE67CA1Q78889471-49F4EC3C-24EF-4815-ADA0-7E9F173FAD27Q80127988-8CC49183-A80E-495C-A72B-E601507B831DQ80134358-907868DC-D4FA-4FE4-A374-8E6DF5B35A1FQ82653340-A63927C4-87F7-495E-BE5A-A21C3E643FA6Q83202662-8F87488E-1382-4842-9084-54093D8496A1Q84392366-64ED785D-25E9-4233-A216-2A1B9990F358Q85649060-77967938-524C-4E78-A7B5-CE52F423B36EQ90231446-8153D748-5F45-47B0-86B9-4E9E9BB873FBQ92755644-C58E7AC7-681A-44BC-9797-FD9427285FC2
P50
description
researcher
@en
հետազոտող
@hy
name
Fernando Cardona
@ast
Fernando Cardona
@en
Fernando Cardona
@es
Fernando Cardona
@nl
type
label
Fernando Cardona
@ast
Fernando Cardona
@en
Fernando Cardona
@es
Fernando Cardona
@nl
prefLabel
Fernando Cardona
@ast
Fernando Cardona
@en
Fernando Cardona
@es
Fernando Cardona
@nl
P106
P21
P31
P496
0000-0003-4460-6824